UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of October 2023

 

 

Commission File Number: 001-39633

 

 

Abcam plc

(Translation of registrant’s name into English)

 

 

Discovery Drive

Cambridge Biomedical Campus

Cambridge, CB2 0AX

United Kingdom

(Address of principal executive office)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒    Form 40-F ☐

 

 

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

On October 12, 2023, Abcam plc (the “Company”) issued a press release (the “Announcement”) announcing the publication of an investor presentation (the “Investor Presentation”) and the publication and mailing of a letter from the Independent Directors of the Company urging shareholders to vote in support of the Company’s agreement to be acquired for $24.00 per share by Danaher Corporation. A copy of the Announcement and Investor Presentation are furnished herewith as Exhibits 99.1, and 99.2, respectively, to this Report of Foreign Private Issuer on Form 6-K.

EXHIBIT INDEX

 

Exhibit No.		Description
99.1		Announcement dated October 12, 2023
99.2		Investor Presentation dated October 12, 2023

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

		ABCAM PLC
Date: October 12, 2023		By:		/s/ Alan Hirzel
				Name:		Alan Hirzel
				Title:		Chief Executive Officer